Abscess: Clinical Trials

19 trials for Abscess, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed. 19 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 219Completed 19
Phase 31Completed 1

Follow Abscess: new trials by email Literature Review of Abscess trials Research Report on Abscess

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)
Avacopan, Placebo - Hidradenitis Suppurativa, Acne Inversa
Phase 2CompletedAmgen4352018-12-212025-03-17
Systemic and Local Antimicrobials in the Management of Dental Abscess in Children
Odontopaste®, Pulpdent, Amoxicillin - Dentoalveolar Abscess
Phase 2CompletedUniversity of Malaya552018-09-182020-05-12
Resolution of Pain and Swelling After the Use of Neem Leaf Extract Compared to Chlorhexidine Gluconate as an Intracanal Irrigant During Pulpectomy
Neem leaf extract, Chlorhexidine gluconate - Periapical Abscess
Phase 2 / Phase 3CompletedCairo University402016-12-012019-07-31
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Daptomycin, Brilacidin - Skin Infection, Bacterial Infection
Phase 2CompletedCellceutix Corporation2152014-02-012018-09-26
Laparoscopic Management of Periappendicular Abscess
Laparoscopic appendectomy, Conservative management with percutaneous drainage - Appendicitis, Abdominal Abscess
Phase 2CompletedHelsinki University Central Hospital602011-01-012014-09-23
Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)
JNJ-32729463, linezolid, JNJ-32729463 placebo - Complicated Skin and Skin Structure Infections
Phase 2CompletedFuriex Pharmaceuticals, Inc1612010-06-012011-12-16
Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
adalimumab, Placebo - Hidradenitis Suppurativa
Phase 2CompletedAbbott1542009-04-012011-05-09
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Trimethoprim-sulfamethoxazole, Placebo, Clindamycin - Staphylococcal Infection
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)13102009-04-012016-03-17
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
Type of dressing - Iodoform, Type of dressing - Aquacel - Abscess, Cellulitis
Phase 2CompletedValleywise Health922008-03-012017-10-04
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
ceftaroline, linezolid, Aztreonam - Bacterial Infection
Phase 2CompletedForest Laboratories1502008-02-012017-03-14
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
Radezolid, Linezolid - Infectious Skin Diseases, Bacterial Skin Diseases
Phase 2CompletedMelinta Therapeutics, Inc.1502007-12-012014-03-27
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.1462007-10-012019-03-19
A Study for Patients With Complicated Skin and Skin Structure Infections
oritavancin - Staphylococcal Skin Infections, Wounds and Injuries
Phase 2CompletedTarganta Therapeutics Corporation2942007-08-012008-08-14
Comparison of Suturing and Packing of Drained Abscesses
PRIMARY CLOSRE, SECONDARY CLOSURE, SPONTANEOUS HALING - Cutanoeus Abscesses
Phase 2CompletedStony Brook University1002007-01-012012-10-22
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
Alteplase, saline - Abdominal Abscess, Pelvic Abscess
Phase 2CompletedKaiser Permanente202006-02-012015-02-26
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Telavancin, vancomycin or antistaphylococcal penicillin - Infections, Gram-positive Bacterial
Phase 2CompletedCumberland Pharmaceuticals2012004-02-012019-01-16
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Telavancin, Vancomycin or antistaphylococcal penicillin - Infections, Gram-Positive Bacterial, Abscess
Phase 2CompletedCumberland Pharmaceuticals1692003-06-012019-01-16
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
Sulfadiazine, Clarithromycin, Atovaquone - Toxoplasmosis, Cerebral, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1002021-10-28
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1502021-11-02

Narrower conditions

Cellulitis (8)  ·  Wound Infection (5)  ·  Bacterial Infections (4)  ·  Abdominal Abscess (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Burns (2)  ·  HIV Infections (2)  ·  Hidradenitis Suppurativa (2)  ·  Periapical Abscess (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)  ·  Staphylococcal Infections (2)  ·  Staphylococcal Skin Infections (2)

Broader conditions

Infections (19)  ·  Suppuration (19)  ·  Pathologic Processes (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Inflammation (12)  ·  Bacterial Infections and Mycoses (11)  ·  Skin and Connective Tissue Diseases (11)  ·  Skin Diseases, Infectious (9)  ·  Connective Tissue Diseases (8)  ·  Bacterial Infections (7)  ·  Gram-Positive Bacterial Infections (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Bacterial (4)  ·  Blood-Borne Infections (2)

Interventions

Linezolid (3)  ·  Leucovorin (2)  ·  Pyrimethamine (2)  ·  Vancomycin (2)  ·  telavancin (2)  ·  Adalimumab (1)  ·  Amoxicillin (1)  ·  Atovaquone (1)  ·  Aztreonam (1)  ·  Ceftaroline (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Clarithromycin (1)  ·  Clindamycin (1)  ·  Conservative Treatment (1)  ·  Daptomycin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Cumberland Pharmaceuticals (2)  ·  Abbott (1)  ·  Amgen (1)  ·  Cairo University (1)  ·  Cellceutix Corporation (1)  ·  Forest Laboratories (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  Helsinki University Central Hospital (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Kaiser Permanente (1)  ·  Melinta Therapeutics, Inc. (1)  ·  Stony Brook University (1)  ·  Targanta Therapeutics Corporation (1)  ·  University of Malaya (1)

Countries

United States (15)  ·  Australia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Romania (1)  ·  Ukraine (1)

Top investigators

G. Ralph Corey, MD (2)  ·  Adam J Singer, MD (1)  ·  BJ Luft (1)  ·  Chirgwin K (1)  ·  Dalia M Moheb, Assoc Prof (1)  ·  Hyo-Chun Yoon, MD, PhD (1)  ·  JL Vilde (1)  ·  Lily Azura Shoaib Dr (1)  ·  Luft B (1)  ·  Madhumita Sinha, MD (1)  ·  Martin Okun, MD, PhD (1)  ·  Norhan A El Dokky, Assoc Prof (1)

Results publications

PMID 21537018, PMID 23247938, PMID 23570475, PMID 25785967, PMID 27136622, PMID 28657870, PMID 29380251

NIH funding

2008 (1)